MRI measurements of aortic arch pulse wave velocity allow physicians to predict cognitive decline and cardiovascular diseases.
Aortic arch pulse wave velocity, measured by phase-contrast MRI, provides a highly significant independent predictor of white matter hyperintensity volume, which can indicate cerebral microvascular disease, according to a study published in the journal Radiology.
Researchers from UT Southwestern Medical Center in Dallas evaluated the relationship between aortic stiffness and cerebrovascular disease in 1,270 participants who were part of the multiethnic Dallas Heart Study. The researchers measured the aortic pulse wave velocity with phase-contrast MRI.
Seven years later, the subjects underwent MRIs to measure the volume of any white matter hyperintensity in the brain. The researchers also looked at 15 other cardiovascular risk factors as predictors of white matter hyperintensity, as well as age, gender, and ethnicities.
The authors found that the aortic arch pulse wave velocity helped predict white matter hyperintensity volume independent of the other demographic and cardiovascular risk factors. They estimated that a 1 percent increase in aortic arch pulse wave velocity (meters per second) is related to a 0.3 percent increase in subsequent white matter hyperintensity volume in milliliters, when all other variables are constant.
The authors concluded that the aortic arch pulse wave velocity measured with phase-contrast MRI is an optimal predictive model of subsequent white matter hyperintensity burden, which in turn can predict cardiovascular disease. These measurements provide a distinct contribution along with systolic blood pressure, hypertension treatment, congestive heart failure, and age.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.